Sign in

CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company

Altimmune, Inc.

Sign in to watch
Ticker
ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
202726770
Phone
862-457-1450
Business address
350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
Former names
PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-12-14 Drutz David Director Option exercise +139 $2.40 $334 17,812
2021-12-14 Drutz David Director Option exercise · Stock Options (option to buy) −139 0
2021-11-30 Garg Vipin K President and CEO Shares withheld for taxes −3,007 $10.49 $32K 286,563
2021-11-19 Drutz David Director Option exercise +70 $2.40 $168 17,673
2021-11-19 Drutz David Director Option exercise · Stock Options (option to buy) −70 0
2021-10-30 Garg Vipin K President and CEO Shares withheld for taxes −3,007 $10.80 $32K 289,570
2021-09-30 Garg Vipin K President and CEO Shares withheld for taxes −3,007 $11.31 $34K 292,577
2021-09-23 Jorkasky Diane Director Grant or award · Stock Options (option to buy) +24,100 24,100
2021-09-23 Schafer Klaus Director Grant or award · Stock Options (option to buy) +24,100 24,100
2021-09-23 SAYARE MITCHEL Director Grant or award · Stock Options (option to buy) +24,100 24,100
2021-09-23 Pisano Wayne Director Grant or award · Stock Options (option to buy) +24,100 24,100
2021-09-23 Hodges Philip Director Grant or award · Stock Options (option to buy) +24,100 24,100
2021-09-23 GILL JOHN Director Grant or award · Stock Options (option to buy) +24,100 24,100
2021-09-23 Drutz David Director Grant or award · Stock Options (option to buy) +24,100 24,100
2021-08-30 Garg Vipin K President and CEO Shares withheld for taxes −3,008 $14.09 $42K 295,584
2021-07-31 Harris Matthew Scott Chief Medical Officer Grant or award +725 $7.71 $6K 5,762
2021-07-31 Brown William Michael Chief Financial Officer Grant or award +803 $7.71 $6K 17,721
2021-07-31 Roberts M Scot Chief Scientific Officer Grant or award +1,750 $7.71 $13K 11,611
2021-07-30 Garg Vipin K President and CEO Shares withheld for taxes −3,007 $9.07 $27K 298,592
2021-06-30 Garg Vipin K President and CEO Shares withheld for taxes −3,007 $9.85 $30K 301,599

Page 19 of 29 · 568 trades